Dysregulation of the PD-1/PD-L1 pathway contributes to the pathogenesis of celiac disease.
作者信息
Ponce de León Candelaria, Angel López-Casado Miguel, Lorite Pedro, Palomeque Teresa, Isabel Torres María
机构信息
Department of Experimental Biology, University of Jaén, Jaén, Spain.
Department of Pediatrics Gastroenterology, Hospital Virgen de las Nieves, Granada, Spain.
出版信息
Cell Mol Immunol. 2019 Sep;16(9):777-779. doi: 10.1038/s41423-019-0256-7. Epub 2019 Jun 26.
Abstract
摘要
相似文献
1
Dysregulation of the PD-1/PD-L1 pathway contributes to the pathogenesis of celiac disease.
Cell Mol Immunol. 2019 Sep;16(9):777-779. doi: 10.1038/s41423-019-0256-7. Epub 2019 Jun 26.
2
Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity.
Am J Respir Crit Care Med. 2014 Sep 1;190(5):560-71. doi: 10.1164/rccm.201401-0188OC.
3
The PD-1/PD-L1 pathway in human pathology.
Curr Mol Med. 2012 Mar;12(3):259-67. doi: 10.2174/156652412799218903.
4
Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas.
World J Gastroenterol. 2019 Apr 14;25(14):1684-1696. doi: 10.3748/wjg.v25.i14.1684.
5
The co-inhibitory molecule PD-L1 contributes to regulatory T cell-mediated protection in murine crescentic glomerulonephritis.
Sci Rep. 2019 Feb 14;9(1):2038. doi: 10.1038/s41598-018-38432-3.
6
Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway.
PLoS Pathog. 2014 Mar 13;10(3):e1003993. doi: 10.1371/journal.ppat.1003993. eCollection 2014 Mar.
7
Combination immunotherapy with interleukin-2 surface-modified tumor cell vaccine and programmed death receptor-1 blockade against renal cell carcinoma.
Cancer Sci. 2019 Jan;110(1):31-39. doi: 10.1111/cas.13842. Epub 2018 Dec 1.
8
[Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 Apr 7;55(4):384-390. doi: 10.3760/cma.j.cn115330-20190618-00392.
9
Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy.
J Immunother. 2016 Oct;39(8):306-15. doi: 10.1097/CJI.0000000000000136.
10
Reactive glia promote development of CD103 CD69 CD8 T-cells through programmed cell death-ligand 1 (PD-L1).
Immun Inflamm Dis. 2018 Jun;6(2):332-344. doi: 10.1002/iid3.221. Epub 2018 Mar 30.
引用本文的文献
1
Expression of Elafin and CD200 as Immune Checkpoint Molecules Involved in Celiac Disease.
Int J Mol Sci. 2024 Jan 10;25(2):852. doi: 10.3390/ijms25020852.
2
Characteristics, treatment, and outcome of diverticulitis after immune checkpoint inhibitor treatment in patients with malignancies.
J Cancer Res Clin Oncol. 2023 Jul;149(8):4805-4816. doi: 10.1007/s00432-022-04405-3. Epub 2022 Oct 15.
3
Constitutive programmed death ligand 1 expression protects gastric G-cells from Helicobacter pylori-induced inflammation.
Helicobacter. 2022 Oct;27(5):e12917. doi: 10.1111/hel.12917. Epub 2022 Jul 28.
4
Checkpoint Inhibitors and Induction of Celiac Disease-like Condition.
Biomedicines. 2022 Mar 4;10(3):609. doi: 10.3390/biomedicines10030609.
5
Significance of PD1 Alternative Splicing in Celiac Disease as a Novel Source for Diagnostic and Therapeutic Target.
Front Immunol. 2021 Jun 16;12:678400. doi: 10.3389/fimmu.2021.678400. eCollection 2021.
6
Role of PD-L1 in Gut Mucosa Tolerance and Chronic Inflammation.
Int J Mol Sci. 2020 Dec 1;21(23):9165. doi: 10.3390/ijms21239165.
7
The Diverse Function of PD-1/PD-L Pathway Beyond Cancer.
Front Immunol. 2019 Oct 4;10:2298. doi: 10.3389/fimmu.2019.02298. eCollection 2019.
本文引用的文献
1
Celiac Disease Autoimmunity.
Arch Immunol Ther Exp (Warsz). 2018 Dec;66(6):423-430. doi: 10.1007/s00005-018-0520-z. Epub 2018 Aug 25.
2
The diverse functions of the PD1 inhibitory pathway.
Nat Rev Immunol. 2018 Mar;18(3):153-167. doi: 10.1038/nri.2017.108. Epub 2017 Nov 13.
3
Potential role of the IL-33/ST2 axis in celiac disease.
Cell Mol Immunol. 2017 Mar;14(3):285-292. doi: 10.1038/cmi.2015.85. Epub 2015 Sep 7.
4
IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.
Br J Cancer. 2015 Apr 28;112(9):1501-9. doi: 10.1038/bjc.2015.101. Epub 2015 Mar 31.
5
Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity.
Autoimmun Rev. 2013 Sep;12(11):1091-100. doi: 10.1016/j.autrev.2013.05.003. Epub 2013 Jun 20.
6
T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.
Gastroenterology. 2012 Mar;142(3):552-61. doi: 10.1053/j.gastro.2011.11.021. Epub 2011 Nov 19.
7
Role of PD-1 in regulating T-cell immunity.
Curr Top Microbiol Immunol. 2011;350:17-37. doi: 10.1007/82_2010_116.
8
Depletion of the programmed death-1 receptor completely reverses established clonal anergy in CD4(+) T lymphocytes via an interleukin-2-dependent mechanism.
Cell Immunol. 2009;256(1-2):86-91. doi: 10.1016/j.cellimm.2009.01.008. Epub 2009 Feb 23.
9
Regulatory T-cell function is impaired in celiac disease.
Dig Dis Sci. 2009 Jul;54(7):1513-9. doi: 10.1007/s10620-008-0501-x. Epub 2008 Oct 31.
10
Alternative splice variants of the human PD-1 gene.
Cell Immunol. 2005 Jun;235(2):109-16. doi: 10.1016/j.cellimm.2005.07.007. Epub 2005 Sep 19.
Zotero 插件